Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries (ZoMaxx™ II)

This study has been completed.
Information provided by (Responsible Party):
Abbott Vascular Identifier:
First received: August 30, 2005
Last updated: January 6, 2012
Last verified: January 2012